6Marra F, Marra CA, Moadebi S, et al. Levofloxacin treatment of active tuber- culosis and the risk of adverse events. Chest.2005, ,18(3 ) : 1406-1413.
7Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med.2002,137( 12):947-954.
8Makhlouf HA, Hehny A, Fawzy E,et al.A prospective study of antituberculous drug-induced hepalotoxicity in an area endemic for liver diseases. Hepalol int. 2008,2(3):353-360.